R&D Portfolio
Resources
Here you will find all our documents, brochures and posters of interest to you.
Posters
App. Notes
Gallery
Brochures
Blog
RESOURCES
Posters
Ensure the safety of your new molecule!
Our new application notes on CacoReady plates will show you how to accurately predict and stratify intestinal toxicity using cutting-edge methods like TEER and LY paracellular flux.
Get for free the latest protocol for acute toxicity assessment.
RESOURCES
Gallery
RESOURCES
Brochures
CacoReady
CacoGoblet
PreadyPort WT 24w
PreadyPort WT 96w
PreadyPort MDR1 24w
PreadyPort MDR1 96w
PreadyPort BCRP 24w
PreadyPort BCRP 96w
PreadyTake MATE1
PreadyTake OCT2
PreadyTake OATP1B3
Our latest news
ReadyCell presented its latest software implementation at the Exact Event in Barcelona
This software was specially designed to manage our customers’ orders, as well as to automate the management of documentation and quality controls, facilitating orders worldwide and speeding up the generation of the necessary documents for customs.
A pioneering investigation unveils novel allosteric inhibitors of SHP2 in cancer therapy
In a recent publication in the Journal of Medicinal Chemistry, a collaborative research led by the scientist Dr. H. Day, in conjunction with a consortium of researchers, explored the development of allosteric inhibitors targeting SH2 domain-containing protein tyrosine...
ReadyCell at the Bio-Europe Spring 2024
ReadyCell is attending BIO-Europe Spring in Barcelona. The event is expected to bring together executives from biotech and pharma companies.
Happy International Women’s Day!
With this infographic, we proudly show the key facts we have achieved in recent times in promoting gender equality and women’s rights in the company.
Promising results for a new treatment against drug-resistant tuberculosis
The article highlights the discovery of a series of azetidine derivatives, known as BGAz compounds, that exhibit potent bactericidal activity against both drug-sensitive Mycobacterium tuberculosis and multidrug-resistant TB strains.
Get to know our talented women from Readycell
In honor of the International Day of Women and Girls in Science, we present a series of videos featuring insights from our team members that explore the diverse experiences and perspectives of the talented women at ReadyCell.
New Insights into drug formulation with ready-to-use Caco-2 cells
In a recent study published in the Future Pharmacology Journal, researchers from prestigious French companies examined the impact of four polyols on the permeability of seven active pharmaceutical ingredients (APIs).
Happy Holidays and a Prosperous New Year!
To convey our spirit, we share a Christmas card, proudly supported by ASHOFI, dedicated to aiding individuals affected by fibromyalgia.
3DLIVER: Celebrating one year of progress in the project for advanced drug toxicity testing and discovery
The main aim of the 3DLIVER project is the generation of innovative human liver-derived 3D in vitro models as innovative ready-to-use kits for drug testing models, using human liver cells and extracellular matrix (ECM), to generate more reliable in vitro drug testing devices.
